Patents
Patents for C07D 211 - Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings (37,939)
08/2008
08/21/2008US20080200521 Novel hydroxamic acid containing amino acid derivatives
08/21/2008US20080200512 Hepatitis C virus polymerase inhibitors
08/21/2008US20080200511 Novel Compounds and Methods of Using the Same
08/21/2008US20080200507 Water and organic solvent free crystal lattice; hydrophobic, water soluble; endometriosis and/or uterine leiomyoma; commercial scale; X ray diffraction pattern having peaks at 13.0, 13.6, 18.6, 19.0, 21.0 and 22.3 degrees
08/21/2008US20080200466 Organic Compounds For the Treatment of Inflammatory or Allergic Conditions
08/21/2008US20080200460 Chemical Compounds
08/21/2008US20080200444 Soluble epoxide hydrolase inhibitors
08/21/2008US20080199454 Caspase inhibitor prodrugs
08/20/2008EP1958935A2 Process for the production of piperidine derivatives with microorganisms
08/20/2008EP1957458A2 5-(arylsulfonyl)-pyrazolopiperidines
08/20/2008EP1957449A1 Compounds for the treatment of inflammatory disorders and microbial diseases
08/20/2008EP1957448A1 Substituted azacycloalkanes useful for treating cns conditions
08/20/2008EP1957058A1 Compounds for the treatment of inflammatory disorders and microbial diseases
08/20/2008EP1685102A4 Melanocortin receptor agonists
08/20/2008EP1569647B1 Cyclohexyl compounds as ccr5 antagonists
08/20/2008EP1337251B1 Monocyclic or bicyclic carbocycles and heterocycles as factor xa inhibitors
08/20/2008EP1249233B1 Npyy5 antagonists
08/20/2008CN101248069A Androgen receptor modulators and method of treating disease using the same
08/20/2008CN101248042A Sulfonamide compounds and uses thereof
08/20/2008CN100411686C Visual function improving agents
08/19/2008US7414134 B1 bradykinin receptor antagonists
08/19/2008US7414057 Piperazine urea derivatives as melanocortin-4 receptor agonists
08/14/2008US20080194830 efficiently and in high yield; insecticide intermediates;
08/14/2008US20080194829 Process for catalytically preparing aromatic or heteroaromatic nitriles
08/14/2008US20080194827 converting Donepezil hydrochloride to said Donepezil
08/14/2008US20080194826 4-aminopiperidines react with 2-furancarboxylic acid or 2-furoyl chloride; opiod antagonist
08/14/2008US20080194816 Method of producing an o-disubstituted aromatic compound, and method of producing a monosubstituted-monohaloaromatic compound
08/14/2008US20080194650 Aryl fluoroethyl ureas acting as alpha 2 adrenergic agents
08/14/2008US20080194648 glutamate receptors agonists; especially to treat psychotic conditions, including schizophrenia and enhancement of cognition; N-{-2-[4-(6-fluoro-3-pyridinyl)phenyl]cyclopropyl}-2-propanesulfonamide
08/14/2008US20080194645 N-[3-(4-chlorophenyl)-2-(3-pyridyl)-1-methylpropyl]-2-(5-trifluoromethyl-2-pyridyloxy)-2-methylpropanamide; obesity; antipsychotic agents; synergistic; cannabinoid receptor antagonists
08/14/2008US20080194633 E.g., [(1-(2-aminoacetyl)-4-{N-[(3-fluoro-2-methylphenyl)methyl]carbamoyl}(4-piperidyl))methoxy]-N-(4-ethylphenyl)carboxamide; smooth muscle myosin or non-muscle myosin modulator; hypotensive agent; asthma, COPD, bronchoconstrictive disease, glaucoma, pre-menstrual cramps, erectile dysfunction
08/14/2008US20080194632 Antiinflammatyory agents; asthma therapy; chronic obstructive pilmonary disease
08/14/2008US20080194629 3-Mono-and 3,5-Disubstituted Piperidine Derivatives as Renin Inhibitors
08/14/2008US20080194628 Alzheimer's disease; cognition activators
08/14/2008US20080194551 Acetylene Derivatives
08/14/2008US20080194537 Tetrapeptide capable of inhibiting binding of the Smac protein to Inhibitors of apoptosis, thus promoting apoptosis or sensitizing cells; antiproliferative and anticarcinogenic agents
08/14/2008US20080194520 Sulfonyl Amino Cyclic Derivatives and Use Thereof
08/14/2008CA2677241A1 Compounds that inhibit cholinesterase
08/13/2008EP1954677A1 Thiomorpholine compound and process for preparing the same
08/13/2008EP1954676A2 Process for making donepezil
08/13/2008EP1753763B1 Indazole and indolone derivatives and their use as pharmaceuticals
08/13/2008EP1620401A4 Phenyl substituted cyclic derivatives
08/13/2008EP1572632B1 Tetrahydro-naphthalene derivatives as vanilloid receptor antagonists
08/13/2008EP1453501B1 N- aryl-n'-arylcycloalkyl-urea derivatives as mch antagonists for the treatment of obesity
08/13/2008CN101239982A Alkaloids compounds with hepatitis virus resisting activity
08/13/2008CN101239971A Biphenyl derivatives
08/13/2008CN101239970A Biphenyl derivatives
08/13/2008CN101239969A Biphenyl derivatives
08/13/2008CN101239968A Biphenyl derivatives
08/13/2008CN100410250C Spiroheterocyclic compoundsus reversible inhibitors of cysteine proteases
08/13/2008CN100410242C Pregabalin intermediate and process for preparing same
08/13/2008CN100410236C Substituted methylene amide derivatives as modulators of protein tyrosine phosphatases(ptps)
08/13/2008CN100410234C Asymmetric-synthesis catalyst based on chiral broensted acid and method of asymmetric synthesis with the catalyst
08/13/2008CN100409844C Noval compound, its synthetizing process and therapeutic use
08/12/2008US7411100 Process for the preparation of ring compounds
08/12/2008US7411093 e.g. 2-(2-methoxy-phenyl)-cyclohexylamine; dipeptidyl-peptidase inhibitor; antidiabetic agent; non-insulin dependent diabetes mellitus, and impaired glucose tolerance, obesity, metabolic syndrome or beta -cell protection
08/12/2008US7411072 e.g. 5-(10,11-Dihydro-dibenzo[a,d]cyclohepten-5-ylidenemethyl)-3H-benzooxazol-2-one; antiinflammatory, antidiabetic agent; electrolytes and water retention modulator; hypotensive, hypoglycemic agent; arrhythmias, myocardial fibrosis, osteoporosis, polyuria, polydipsia, Crohn's disease
08/12/2008US7410995 N-linked sulfonamide of heterocyclic thioesters for vision and memory disorders
08/12/2008US7410984 novel pyridone derivatives capable of inhibiting alpha 4 integrin mediated cell adhesion; to treat chronic inflammatory diseases; 3-(4-{2-Oxo-3-[4-(3-o-tolyl-ureido)phenyl]-2H-pyridin-1-ylmethyl}phenyl)propionic acid; hydrolysis
08/12/2008US7410971 1,2-di(cyclic)substituted benzene compounds
08/12/2008US7410970 Substituted 1,4,-di-piperidin-4-yl-piperazine derivatives and their use as neurokinin antagonists
08/12/2008US7410961 2,6-disubstituted piperiddines as modulators
08/12/2008US7410956 Caspase inhibitor prodrugs
08/12/2008US7410506 Dicationic bis-hydrazone compound, dye composition comprising at least one such compound, implementation process therefor and uses thereof
08/07/2008WO2008094862A1 Processes for the preparation of piperidinyl-substituted urea compounds
08/07/2008WO2008093881A1 Method for synthesis of nitroxyl radical
08/07/2008WO2008093737A1 Amide derivative
08/07/2008WO2008092844A1 Piperidin-acetamide derivatives for the treatment of inflammatory or allergic diseases
08/07/2008WO2008092832A1 Method for producing ammonium hexafluorophosphates
08/07/2008WO2008057681A3 Thiophene compounds
08/07/2008US20080188665 hydrogenation of cyanopyridines with hydrogen under increased pressure optionally in the presence of a catalyst containing Ni, Fe or Co and/or ammonia; industrial scale; without expensive precious metal catalysts; chemical intermediate in manufacture of drugs such as flecainide
08/07/2008US20080188659 Method for Preparing Halogenated Amines
08/07/2008US20080188654 Compounds for treatment of inflammation, diabetes and related disorders
08/07/2008US20080188529 N1-(cyanomethyl)-N2-(2,2,2-trifluoro-1-phenylethyl)-L-leucinamide; antiarthritic agent; osteoporosis and other bone loss disorders
08/07/2008US20080188519 Novel azacyclic ethynyl derivatives
08/07/2008US20080188489 Cell differentiation inducer
08/07/2008US20080188485 4-piperazine-4-piperidine-1-ketone derivatives; graft v. host disease, arthritis, rheumatoid arthritis, inflammatory bowel disease, atopic dermatitis, psoriasis, asthma, allergies or multiple sclerosis; human immunodeficiency viricides
08/07/2008US20080188477 Substituted heterocycles, their use as medicament, and pharmaceutical preparations comprising them
08/07/2008CA2676162A1 Method for producing ammonium hexafluorophosphates
08/07/2008CA2675448A1 Processes for the preparation of piperidinyl-substituted urea compounds
08/07/2008CA2675348A1 Piperidin-acetamide derivatives for the treatment of inflammatory or allergic diseases
08/06/2008EP1953142A1 Process for the preparation of antihistaminic 4-diphenylmethyl piperidine derivatives
08/06/2008EP1951719A2 Certain chemical entities, compositions, and methods
08/06/2008EP1951700A2 Novel processes for the preparation of piperazinyl and diazapanyl benzamide derivatives
08/06/2008EP1951670A2 Organic compounds
08/06/2008EP1951652A1 Process for preparing beta- (fluorophenyl) -propanoate ester derivatives
08/06/2008EP1951250A2 Chemical compounds
08/06/2008EP1568702A4 Palladium complexes with heterocyclic ligands
08/06/2008EP1439169B1 Difluoroalkene derivative, pest control agent containing the same, and intermediate therefor
08/06/2008EP1311475B1 Aminocyclohexane derivatives
08/06/2008CN101238104A Salt ó¾
08/06/2008CN101238103A New saltó±
08/06/2008CN101238102A New salt ó
08/06/2008CN101235030A 1-substituted-5-trifluoromethyl-2-(1H)pyridone compound, preparation method and use thereof
08/06/2008CN100407922C Antimicrobial additive and ink composition containing said additive
08/05/2008US7408067 Neuregulins such as 4-(4-Hydroxyphenylthio)-piperidine trifluoroacetate for treatment of dysfunctions of central and autonomic nervous systems
08/05/2008US7407974 e.g. 4-Methoxy-pyrrolidine-1,2-dicarboxylic acid 1-[(4-chloro-phenyl)-amide] 2-{[2-fluoro-4-(2-oxo-2H-pyridin-1-yl)-phenyl]-amide}; anticoagulant, thrombolytic agent; thrombus formation within blood vessels; cardiovascular disease
08/05/2008US7407972 e.g. 4,5-Dihydro-pyrazole-1,5-dicarboxylic acid 1-[(4-chloro-phenyl)-amide] 5-[(3-fluoro-2'-methanesulfonyl-biphenyl-4-yl)-amide]; anticoagulant, thrombolytic agent; thrombus formation within blood vessels; cardiovascular disease
08/05/2008US7407959 N1-(1-cyanocyclopropyl)-N2-(1-{4'-[2,2-difluoro-1-hydroxyethyl]biphenyl-4-yl}-2,2,2-trifluorethyl)-4-fluoro-L-leucinamide; antiarthritic agent; osteoporosis and other bone loss disorders
08/05/2008CA2409614C Separation of the enantiomers of piperidone derivatives with simultaneous racemisation in situ of the unwanted enantiomer
1 ... 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 ... 380